BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19814921)

  • 1. Immunomodulators in asthma therapy.
    Dimov VV; Stokes JR; Casale TB
    Curr Allergy Asthma Rep; 2009 Nov; 9(6):475-83. PubMed ID: 19814921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulators for allergic respiratory disorders.
    Casale TB; Stokes JR
    J Allergy Clin Immunol; 2008 Feb; 121(2):288-96; quiz 297-8. PubMed ID: 18269921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulators in the treatment of asthma.
    Long AA
    Allergy Asthma Proc; 2009; 30(2):109-19. PubMed ID: 19463201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine modulation for anti-allergic treatment.
    Pullerits T
    Curr Pharm Des; 2002; 8(20):1845-53. PubMed ID: 12171536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
    D'Amato G; Piccolo A; Salzillo A; Noschese P; D'Amato M; Liccardi G
    Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):225-31. PubMed ID: 19075985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune modulation for treatment of allergic disease.
    Nguyen TH; Casale TB
    Immunol Rev; 2011 Jul; 242(1):258-71. PubMed ID: 21682751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine and anti-cytokine therapy for the treatment of asthma and allergic disease.
    Holgate ST
    Cytokine; 2004 Nov 21-Dec 7; 28(4-5):152-7. PubMed ID: 15588688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel and emerging therapies for asthma.
    Leath TM; Singla M; Peters SP
    Drug Discov Today; 2005 Dec; 10(23-24):1647-55. PubMed ID: 16376825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future forms of immunotherapy and immunomodulators in allergic disease.
    Nguyen TH; Stokes JR; Casale TB
    Immunol Allergy Clin North Am; 2011 May; 31(2):343-65, x-xi. PubMed ID: 21530824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of immunomodulatory cytokines associated with omalizumab therapy for severe persistent asthma.
    Shimizu Y; Dobashi K; Fueki N; Fueki M; Okada T; Tomioka S; Makino S; Mori M
    J Biol Regul Homeost Agents; 2011; 25(2):177-86. PubMed ID: 21880206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab).
    D'Amato G; Bucchioni E; Oldani V; Canonica W
    Treat Respir Med; 2006; 5(6):393-8. PubMed ID: 17154668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
    D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IgE antibodies for the treatment of asthma.
    Buhl R
    Curr Opin Pulm Med; 2005 Jan; 11(1):27-34. PubMed ID: 15591885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for new treatments aimed at IgE immunomodulation.
    Stokes J; Casale TB
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):212-7; quiz 217-9, 271. PubMed ID: 15478378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptors--novel targets in allergic airway disease (probiotics, friends and relatives).
    Feleszko W; Jaworska J; Hamelmann E
    Eur J Pharmacol; 2006 Mar; 533(1-3):308-18. PubMed ID: 16436277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the mast cell in asthma.
    Peachell P
    Curr Opin Pharmacol; 2005 Jun; 5(3):251-6. PubMed ID: 15907911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor modulators: a patent review (2006-2010).
    Basith S; Manavalan B; Lee G; Kim SG; Choi S
    Expert Opin Ther Pat; 2011 Jun; 21(6):927-44. PubMed ID: 21406035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.